Your browser doesn't support javascript.
loading
Recurrent CTNNB1 mutations in craniofacial osteomas.
Baumhoer, Daniel; Berthold, Ruth; Isfort, Ilka; Heinst, Lorena; Ameline, Baptiste; Grünewald, Inga; Thieringer, Florian M; Rudack, Claudia; Wardelmann, Eva; Vieth, Volker; Sperveslage, Jan; Trautmann, Marcel; Hartmann, Wolfgang.
Affiliation
  • Baumhoer D; Bone Tumor Reference Centre at the Institute of Pathology, University Hospital Basel and University of Basel, Schoenbeinstrasse 40, 4031, Basel, Switzerland.
  • Berthold R; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Isfort I; Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Heinst L; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Ameline B; Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Grünewald I; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Thieringer FM; Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Rudack C; Bone Tumor Reference Centre at the Institute of Pathology, University Hospital Basel and University of Basel, Schoenbeinstrasse 40, 4031, Basel, Switzerland.
  • Wardelmann E; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Vieth V; Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
  • Sperveslage J; Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, Spitalstraße 21, 4031, Basel, Switzerland.
  • Trautmann M; Medical Additive Manufacturing Research Group (Swiss MAM), Department of Biomedical Engineering, University of Basel, Gewerbestrasse 14, 4123, Allschwil, Switzerland.
  • Hartmann W; Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
Mod Pathol ; 35(4): 489-494, 2022 04.
Article in En | MEDLINE | ID: mdl-34725446
ABSTRACT
Osteoma is a benign bone forming tumor predominantly arising on the surface of craniofacial bones. While the vast majority of osteomas develops sporadically, a small subset of cases is associated with Gardner syndrome, a phenotypic variant of familial adenomatous polyposis caused by mutations in the APC gene resulting in aberrant activation of WNT/ß-catenin signaling. In a sequencing analysis on a cohort of sporadic, non-syndromal osteomas, we identified hotspot mutations in the CTNNB1 gene (encoding ß-catenin) in 22 of 36 cases (61.1%), harbouring allelic frequencies ranging from 0.04 to 0.53, with the known S45P variant representing the most frequent alteration. Based on NanoString multiplex expression profiling performed in a subset of cases, CTNNB1-mutated osteomas segregated in a defined "WNT-cluster", substantiating functionality of CTNNB1 mutations which are associated with ß-catenin stabilization. Our findings for the first time convincingly show that osteomas represent genetically-driven neoplasms and provide evidence that aberrant WNT/ß-catenin signaling plays a fundamental role in their pathogenesis, in line with the well-known function of WNT/ß-catenin in osteogenesis. Our study contributes to a better understanding of the molecular pathogenesis underlying osteoma development and establishes a helpful diagnostic molecular marker for morphologically challenging cases.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Osteoma / Beta Catenin Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Osteoma / Beta Catenin Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article